Search Results 2161-2170 of 16691 for Epilepsy (Partial Onset)

  1. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

    The purpose of this study is to determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in ...

  2. Clinical trials - Neurology

    The purpose of this study is to understand the role of systemic inflammation in the genesis of seizures in susceptible children by gaining a clearer ...

  3. Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma - Mayo Clinic

    ... partial response (PR))across both standard of care agents administered ... duration of study participation. Use of contraception or abstinence should ...

  4. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Mayo Clinic researchers study new class of ...

  5. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Senolytics reduce COVID-19 symptoms in ...

  6. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. College senior trains in research to benefit ...

  7. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Mayo Clinic's high-tech pursuit of precision ...

  8. Telomere Length Comparison of Diminished and Normal Ovarian Reserve - Mayo Clinic

    Able to get a single blood drawn at Mayo Clinic in Rochester prior to beginning any medications. Exclusion Criteria: Women undergoing ovarian stimulation ...

  9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    ... duration of study participation, and for 4 months after completion of study; should a woman become pregnant or suspect while she or her partner is ...

  10. A Study Of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration - Mayo Clinic

    The purpose of this study is to evaluate the median duration of therapeutic SAA levels with calaspargase pegol. Secondary end points include evaluating a ...